Novavax (NVAX) Tax Provisions (2010 - 2026)

Novavax's Tax Provisions history runs 9 years deep, the most recent figure standing at $985000.0 for Q1 2026.

• On a quarterly basis, Tax Provisions fell 17.92% year-over-year to $985000.0 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 83.2% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, down 82.86% from the prior year.
• Tax Provisions advanced to $985000.0 in Q1 2026 per NVAX's latest filing, from $376000.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $7.4 million in Q4 2024 and bottomed at -$2.3 million in Q4 2022.
• The 5-year median for Tax Provisions is $1.2 million (2023), against an average of $1.2 million.
• Across the five-year window, Tax Provisions sank 128.2% in 2023 and surged 1641.96% in 2024, its largest moves.
• Year by year, Tax Provisions stood at -$2.3 million in 2022, then soared by 174.69% to $1.7 million in 2023, then surged by 341.29% to $7.4 million in 2024, then slumped by 94.95% to $376000.0 in 2025, then soared by 161.97% to $985000.0 in 2026.
• Per Business Quant, the three latest NVAX Tax Provisions figures stand at $985000.0 (Q1 2026), $376000.0 (Q4 2025), and -$657000.0 (Q3 2025).